RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS |
6 Months Ended |
|---|---|
Jun. 30, 2025 | |
| Related Party Transactions [Abstract] | |
| RELATED PARTY TRANSACTIONS | RELATED PARTY TRANSACTIONS Prior to March 18, 2025, we had an investment in Medalogix, a healthcare predictive data and analytics company, which was accounted for under the equity method of accounting. We incurred costs of approximately $2.7 million during the period January 1, 2025 through March 17, 2025 and $3.2 million and $6.1 million during the three and six-month periods ended June 30, 2024, respectively, in connection with our usage of Medalogix's analytics platforms. Effective March 18, 2025, Medalogix was combined with a healthcare referral and workflow management company, creating a new company, which is accounted for under the equity method of accounting (see Note 3 - Investments for additional information). We incurred costs of approximately $4.5 million and $5.1 million during the three-month period ended June 30, 2025 and the period March 18, 2025 through June 30, 2025 in connection with our usage of these platforms. We have an investment in a technology-enabled clinician sourcing application, which is accounted for under the cost method of accounting. We incurred costs of approximately $0.6 million and $1.4 million during the three and six-month periods ended June 30, 2025, respectively, and $0.2 million and $0.5 million during the three and six-month periods ended June 30, 2024, respectively, in connection with our usage of the technology-enabled clinician sourcing application's services.
|